2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Conditions
Carcinoma, Non-Small-Cell Lung
609
Lung Neoplasms
191
Neoplasms
69
Neoplasm Metastasis
47
Mesothelioma, Malignant
46
Adenocarcinoma of Lung
42
Mesothelioma
40
Colorectal Neoplasms
30
Carcinoma
24
Breast Neoplasms
23
Parkinson Disease 4, Autosomal Dominant Lewy Body
21
Meningeal Carcinomatosis
20
Head and Neck Neoplasms
19
Brain Neoplasms
18
Ovarian Neoplasms
17
Adenocarcinoma
15
Small Cell Lung Carcinoma
14
NSCLC
14
Pancreatic Neoplasms
13
Melanoma
12
Squamous Cell Carcinoma of Head and Neck
11
Recurrence
11
Neoplasms by Site
10
Lung Diseases
10
Carcinoma, Transitional Cell
10
Uterine Cervical Neoplasms
9
Adenocarcinoma, Bronchiolo-Alveolar
9
Thoracic Neoplasms
8
Non-squamous Non-small Cell Lung Cancer
8
Carcinoma, Bronchogenic
8
Interventions
pralsetinib
1
pembrolizumab
1
Pemetrexed
1
Paclitaxel
1
Gemcitabine
1
Cisplatin
1
Carboplatin
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bronchial Diseases
×
Pemetrexed
×
Clear all
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts